AtroPen

AtroPen is a brand name of atropine, approved by the FDA in the following formulation(s):

ATROPEN (atropine - injectable; injection)

• 
  Manufacturer: MERIDIAN MEDCL TECHN
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): EQ 2MG SULFATE/0.7ML ^[RLD]


• 
  Manufacturer: MERIDIAN MEDCL TECHN
  
  Approval date: June 19, 2003
  
  Strength(s): EQ 0.5MG SULFATE/0.7ML ^[RLD], EQ 1MG SULFATE/0.7ML ^[RLD]


• 
  Manufacturer: MERIDIAN MEDCL TECHN
  
  Approval date: September 17, 2004
  
  Strength(s): EQ 0.25MG SULFATE/0.3ML ^[RLD]

Has a generic version of AtroPen been approved?

No. There is currently no therapeutically equivalent version of AtroPen available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of AtroPen. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with AtroPen.

See also...

• Atropine Consumer Information (Wolters Kluwer)
• Atropine Tablets Consumer Information (Wolters Kluwer)
• Atropine Consumer Information (Cerner Multum)
• Atropine AHFS DI Monographs (ASHP)
• Atropine Sulfate AHFS DI Monographs (ASHP)